Ausgabe 4/2021
Inhalt (4 Artikel)
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy
Sara Small, Shuo Ma
Molecular Testing and Diagnostics (J Khoury, Section Editor)
The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition
Rashmi Kanagal-Shamanna
Health Economics (N Khera, Section Editor)
Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments
Praveen Ramakrishnan Geethakumari, Dheepthi Perumal Ramasamy, Bhagirathbhai Dholaria, Jesús Berdeja, Ankit Kansagra
Open Access
T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
Amyloidosis with Cardiac Involvement: Identification, Characterization, and Management
Faizi Jamal, Michael Rosenzweig